More than $5.5 million of CIHR funding awarded to NMD4C members to strengthen neuromuscular research capacity in Canada
Congratulations to the recipients of the Fall 2022 CIHR funded project grant competition! Seven projects were awarded (>5.5M) to NMD4C members to advance neuromuscular research in Canada: Drs. Rashmi Kothary and Cynthia Gagnon (steering committee members); Dr. Bernard Brais (investigator); Drs. Elise Duchesne (2 projects funded) and Gerald Pfeffer (working group members); and Drs. Yan Burelle, Nicolas Dumont (2 projects funded), Penney Gilbert, Luc Hébert, Mireille Khacho, Keir Menzies, Louise Moyle, and Toshifumi Yokota (members). Of note, 6/7 of the funded projects were awarded to early-career researchers (Drs. Nicolas Dumont, Elise Duchesne, Mireille Khacho, and Louise Moyle). Further information on the funding recipients can be found below.
Project Title: Extra-neuronal contribution to spinal muscular atrophy disease pathogenesis ($818,550).
Principal Investigator: Dr. Rashmi Kothary; Ottawa Hospital Research Institute
Project Title: Regulation of satellite stem cell fate by LINC complex proteins ($1,071,000).
Principal Investigator: Dr. Penney Gilbert; University of Toronto
Co-Investigators: Drs. Louise Moyle and Aaron Wheeler
Project Title: Therapeutic potential of bioactive lipids as anti-fibrotic therapy for muscle regeneration and dystrophies ($757,350).
Principal Investigator: Dr. Nicolas Dumont; Centre hospitalier universitaire Sainte-Justine (Montréal, Québec)
Project Title: Targeting defective cells to restore myogenesis and muscle function in myotonic dystrophy type 1 ($761,175).
Principal Investigators: Drs. Nicolas Dumont and Elise Duchesne; Centre hospitalier universitaire Sainte-Justine (Montréal, Québec)
Project Title: IMPACT, a supervised rehabilitation program for spastic ataxias: A rater-blinded, randomized controlled trial ($638,776).
Principal Investigators: Drs. Elise Duchesne, Mylene Aubertin, Bernard Brais, and Cynthia Gagnon; Université du Québec à Chicoutimi
Co-Investigators: Drs. Rubens da Silva, Raquel Fonseca, Luc Hébert, Gerald Pfeffer
Project Title: Mitochondrial Quality Control in Muscle Stem Cells: A Determinant of Cell Fate Decision and Tissue Repair Capacity ($692,325).
Principal Investigator: Dr. Yan Burelle; University of Ottawa
Co-Investigators: Drs. Mireille Khacho, Keir Menzies
Project Title: Neutrophil Responses in Doxorubicin-Induced Myopathy ($879,750).
Principal Investigator: Javier Clemente-Casares; University of Alberta
Co-Investigators: Gavin Oudit, Toshifumi Yokota
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.